医学
双盲
脚(韵律)
糖尿病足
随机对照试验
足部护理
干预(咨询)
临床试验
糖尿病
物理疗法
外科
替代医学
内科学
护理部
安慰剂
病理
内分泌学
语言学
哲学
作者
Frances L. Game,Katie Gray,Daniel Davis,Rachelle Sherman,Kamal Chokkalingam,Zak Connan,Apostolos Fakis,Michael Jones
摘要
Recent reviews suggest that amniotic membrane products may accelerate healing of diabetic foot ulcers. A new dried human amniotic membrane (dHAM) has been used for ocular ulcers but not for diabetic foot ulcers. This was a multi-centre, prospective, patient and observer blind, randomised controlled pilot trial, to investigate whether 2 weekly addition of the dHAM to standard care versus standard care alone increased the proportion of healed participants' index foot ulcers within 12 weeks. Thirty-one people (mean age 59.8 years, 81% male, 87% type 2 diabetes) were randomised (15 dHAM, 16 usual care). Within 12 weeks, healing occurred in 4 (27%) ulcers in the dHAM group versus 1 (6.3%) usual care group (P = .1). Percentage wound area reduction was higher in the dHAM versus control group. (P = .0057). There was no difference in AEs between the two groups. Six participants allocated to dHAM correctly identified their treatment group, although 5 in usual care incorrectly thought they were in the intervention arm. This pilot trial result is encouraging showing that this dHAM preparation is safe and promising treatment. These results will be used to design a statistically powered, definitive double blind randomised controlled trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI